Bausch + Lomb intros PreserVision AREDS 2 minigels
Bausch + Lomb is introducing a new delivery method for its PreserVision AREDS 2 vitamins. The company has launched PreserVision AREDS 2 minigels, which it said would replace the currently offered soft gels and offer an easier-to-swallow offering for consumers.
The vitamins contain a formula recommended by the National Eye Institute for people with moderate-to-advanced age-related macular degeneration, or AMD.
“AMD is a leading cause of vision loss in Americans age 50 and older. For my patients who are diagnosed with moderate to advanced AMD, I typically recommend a plan that includes regular exercise, a healthy diet, and PreserVision — a supplement that contains nutrients recommended by the National Eye Institute to help reduce the risk of AMD progression in these patients,” said Rishi Singh, a physician at the Cole Eye Institute, Cleveland Clinic. “I am pleased to recommend the new PreserVision AREDS 2 minigels to my patients who have inquired about options that could be easier for them to swallow.”
Currently, it is estimated that as many as 16 million people in the United states have age-related macular degeneration. If untreated, it can lead to severe vision loss or blindness.
“We are dedicated to providing eye care professionals and their patients with products that help address their needs,” said Chris Marschall, vice president and general manager, U.S. Consumer Health Care, Bausch + Lomb. “The PreserVision AREDS 2 Formula minigel eye vitamins will provide patients with a new easier-to-swallow option that they can incorporate as part of their doctor-recommended plan.”
PreserVision AREDS 2 minigel eye vitamins currently are available at major retailers nationwide. They are sold in 120-count bottles with a suggested retail price of $32.99.